These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 25821132

  • 1. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
    Shui B, Xia W, Wen C, Ding X.
    J Nat Med; 2015 Jul; 69(3):349-57. PubMed ID: 25821132
    [Abstract] [Full Text] [Related]

  • 2. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
    Koga T, Sato T, Furukawa K, Morimoto S, Endo Y, Umeda M, Sumiyoshi R, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Nakamura H, Kawakami A.
    Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
    [Abstract] [Full Text] [Related]

  • 3. Jieduquyuziyin Prescription alleviates hepatic gluconeogenesis via PI3K/Akt/PGC-1α pathway in glucocorticoid-induced MRL/lpr mice.
    Ji LN, Wu S, Fu DQ, Fang SJ, Xie GQ, Fan YS, Bao J.
    J Ethnopharmacol; 2022 Feb 10; 284():114815. PubMed ID: 34763039
    [Abstract] [Full Text] [Related]

  • 4. Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway.
    Ji L, Hou X, Deng X, Fan X, Zhuang A, Zhang X, Li R.
    Evid Based Complement Alternat Med; 2019 Feb 10; 2019():2357217. PubMed ID: 31781262
    [Abstract] [Full Text] [Related]

  • 5. Jieduquyuziyin prescription enhances CD11a and CD70 DNA methylation of CD4+ T cells via miR-29b-sp1/DNMT1 pathway in MRL/lpr mice.
    Huang S, Peng J, Gan Y, Chen L, Zhu Z, Tian F, Ji L, Fan Y, Zhou C, Bao J.
    J Ethnopharmacol; 2023 Dec 05; 317():116776. PubMed ID: 37343653
    [Abstract] [Full Text] [Related]

  • 6. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
    Koga T, Mizui M, Yoshida N, Otomo K, Lieberman LA, Crispín JC, Tsokos GC.
    Autoimmunity; 2014 Nov 05; 47(7):445-50. PubMed ID: 24829059
    [Abstract] [Full Text] [Related]

  • 7. Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway.
    Ji L, Fan X, Hou X, Fu D, Bao J, Zhuang A, Chen S, Fan Y, Li R.
    Front Pharmacol; 2020 Nov 05; 11():1049. PubMed ID: 32760274
    [Abstract] [Full Text] [Related]

  • 8. Jieduquyuziyin prescription promotes the efficacy of prednisone via upregulating Nrf2 in MRL/lpr kidneys.
    Du L, Feng Y, Wang C, Shi X, Wen C, He Z, Zhang Y.
    J Ethnopharmacol; 2022 Nov 15; 298():115643. PubMed ID: 36031105
    [Abstract] [Full Text] [Related]

  • 9. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
    Qiu F, Li T, Zhang K, Wan J, Qi X.
    Int Immunopharmacol; 2016 Sep 15; 38():31-9. PubMed ID: 27235595
    [Abstract] [Full Text] [Related]

  • 10. Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice.
    Liu J, Ma Q, Sun Q, Luo Q, Wang Y, Wang C, Zhu A, Zhao L, Yin L, Lou J, Dong Y, Qiu P.
    Oxid Med Cell Longev; 2022 Sep 15; 2022():4301033. PubMed ID: 35855861
    [Abstract] [Full Text] [Related]

  • 11. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation.
    Yuan L, Xiao ZT, Huang XZ, Wu MJ, Shi H, Liu AF.
    Ren Fail; 2016 Oct 15; 38(9):1432-1440. PubMed ID: 27416851
    [Abstract] [Full Text] [Related]

  • 12. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV.
    Ichinose K, Juang YT, Crispín JC, Kis-Toth K, Tsokos GC.
    Arthritis Rheum; 2011 Feb 15; 63(2):523-9. PubMed ID: 20954187
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
    Phytomedicine; 2019 Sep 15; 62():152965. PubMed ID: 31129432
    [Abstract] [Full Text] [Related]

  • 14. Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
    Otomo K, Koga T, Mizui M, Yoshida N, Kriegel C, Bickerton S, Fahmy TM, Tsokos GC.
    J Immunol; 2015 Dec 15; 195(12):5533-7. PubMed ID: 26561550
    [Abstract] [Full Text] [Related]

  • 15. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
    Koga T, Hedrich CM, Mizui M, Yoshida N, Otomo K, Lieberman LA, Rauen T, Crispín JC, Tsokos GC.
    J Clin Invest; 2014 May 15; 124(5):2234-45. PubMed ID: 24667640
    [Abstract] [Full Text] [Related]

  • 16. Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.
    Ichinose K, Ushigusa T, Nishino A, Nakashima Y, Suzuki T, Horai Y, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Arima K, Nakamura H, Obata Y, Yamamoto K, Origuchi T, Nishino T, Kawakami A, Tsokos GC.
    Arthritis Rheumatol; 2016 Apr 15; 68(4):944-52. PubMed ID: 26636664
    [Abstract] [Full Text] [Related]

  • 17. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z, Wong CK, Dong J, Chu M, Jiao D, Kam NW, Lam CW, Tam LS.
    Clin Exp Immunol; 2015 Aug 15; 181(2):253-66. PubMed ID: 25845911
    [Abstract] [Full Text] [Related]

  • 18. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
    Gu Z, Tan W, Ji J, Feng G, Meng Y, Da Z, Guo G, Xia Y, Zhu X, Shi G, Cheng C.
    Aging (Albany NY); 2016 May 15; 8(5):1102-14. PubMed ID: 27048648
    [Abstract] [Full Text] [Related]

  • 19. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 15; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 20. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W, Wu-qing W, Zhu-wen Y, Zuo L.
    Lupus; 2014 Sep 15; 23(10):994-1005. PubMed ID: 24756437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.